The Underperform rating suggests that the analyst expects DHC to underperform relative to the market or its peers. However, the increase in the price target from $2 to $3 indicates a slightly improved outlook, which could be seen as a positive sign by investors. The impact on the stock price in the short term is likely neutral as the rating remains Underperform, but the raised price target may provide some support.